BioSpace News Archive

Bio NC

G1 Therapeutics to Participate Virtually in the H.C. Wainwright 24th Annual Global Investment Conference

G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that Jack Bailey, G1’s Chief Executive Officer, and other members of the executive team will participate virtually in the H.C. Wainwright 24th Annual Global Investment Conference.

September 7, 2022
·
1 min read
Genetown

Cullinan Oncology to Participate in the HC Wainwright Global Investment Conference and the Morgan Stanley Healthcare Conference

Cullinan Oncology, Inc. announced that Company management will participate in the following investor conferences.

September 7, 2022
·
2 min read
Pharm Country

Intercept Pharmaceuticals to Conduct Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences

Intercept Pharmaceuticals, Inc. announced that Jerry Durso, President and Chief Executive Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will participate in fireside chats and investor meetings at the following upcoming investor conferences.

September 7, 2022
·
1 min read
Business

Brickell Biotech Announces Corporate Rebranding to Fresh Tracks Therapeutics

Brickell Biotech, Inc. announced that it has changed its name to Fresh Tracks Therapeutics, Inc.

September 7, 2022
·
8 min read
Genetown

Amolyt Pharma to Host Hybrid Key Opinion Leader Event on its Potential Hypoparathyroidism Treatment, AZP-3601, on Monday, September 12th at 1:30pm CT/2:30pm ET in Austin, Texas

Amolyt Pharma announced it will host a hybrid key opinion leader event on the Company’s potential hypoparathyroidism treatment, AZP-3601, on Monday, September 12, 2022, at 1:30 pm CT /2:30 pm ET in Austin, Texas.

September 7, 2022
·
2 min read
BioMidwest

AbbVie to Present at the Morgan Stanley 20th Annual Healthcare Conference

AbbVie will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022.

September 7, 2022
·
1 min read
Genetown

Curis to Present at Upcoming Healthcare Conferences in September 2022

Curis, Inc. announced that James Dentzer, President and Chief Executive Officer of Curis, will present at the H.C. Wainwright 24th Annual Global Investment Conference on Wednesday, September 14, 2022 at 4:00 p.m. ET in New York, NY.

September 7, 2022
·
2 min read
Biotech Bay

Amyris to Participate at September 2022 Investor Conferences

Amyris, Inc. announced that management will participate in fireside chats moderated by equity research analysts, and provide updates, at two upcoming investor conferences.

September 7, 2022
·
1 min read
Deals

Good Therapeutics Announces Acquisition of Conditionally Active PD-1-regulated IL-2 Program by Roche

Good Therapeutics, a privately held company, today announced it has entered into a definitive merger agreement to be acquired by Roche (SIX: RO, ROG; OTCQX: RHHBY).

September 7, 2022
·
3 min read
Drug Development

Salubris Biotherapeutics Announces Updated Phase 1b Data Demonstrating that JK07, the First Investigational Antibody Fusion Protein for Heart Failure, Resulted in Clinically Meaningful Improvements in Ejection Fraction

Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, today announced positive interim data from the ongoing Phase 1b study of JK07 in heart failure with reduced ejection fraction (HFrEF).

September 7, 2022
·
5 min read